S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
Log in
NASDAQ:IRMD

IRadimed Stock Forecast, Price & News

$21.95
+0.11 (+0.50 %)
(As of 10/29/2020 04:30 PM ET)
Add
Compare
Today's Range
$21.63
Now: $21.95
$22.05
50-Day Range
$20.62
MA: $21.74
$22.62
52-Week Range
$14.41
Now: $21.95
$28.43
Volume18,697 shs
Average Volume47,270 shs
Market Capitalization$268.82 million
P/E Ratio51.05
Dividend YieldN/A
Beta1.26
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Read More
IRadimed logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.76 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRMD
CUSIPN/A
Phone407-677-8022
Employees114

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$38.52 million
Cash Flow$0.95 per share
Book Value$4.83 per share

Profitability

Net Income$9.63 million

Miscellaneous

Market Cap$268.82 million
Next Earnings Date10/30/2020 (Confirmed)
OptionableNot Optionable
$21.95
+0.11 (+0.50 %)
(As of 10/29/2020 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











IRadimed (NASDAQ:IRMD) Frequently Asked Questions

How has IRadimed's stock price been impacted by COVID-19?

IRadimed's stock was trading at $22.51 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IRMD shares have decreased by 2.5% and is now trading at $21.95.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of IRadimed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IRadimed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for IRadimed
.

When is IRadimed's next earnings date?

IRadimed is scheduled to release its next quarterly earnings announcement on Friday, October 30th 2020.
View our earnings forecast for IRadimed
.

How can I listen to IRadimed's earnings call?

IRadimed will be holding an earnings conference call on Friday, October 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were IRadimed's earnings last quarter?

IRadimed Co. (NASDAQ:IRMD) announced its earnings results on Thursday, July, 30th. The medical equipment provider reported $0.05 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.12. The medical equipment provider had revenue of $6.80 million for the quarter, compared to the consensus estimate of $5.53 million. IRadimed had a net margin of 14.74% and a return on equity of 9.57%.
View IRadimed's earnings history
.

What price target have analysts set for IRMD?

1 brokers have issued 1 year price objectives for IRadimed's stock. Their forecasts range from $26.00 to $26.00. On average, they expect IRadimed's stock price to reach $26.00 in the next twelve months. This suggests a possible upside of 18.5% from the stock's current price.
View analysts' price targets for IRadimed
.

Are investors shorting IRadimed?

IRadimed saw a drop in short interest in October. As of October 15th, there was short interest totaling 165,700 shares, a drop of 32.9% from the September 30th total of 247,100 shares. Based on an average daily volume of 40,600 shares, the short-interest ratio is presently 4.1 days. Approximately 2.7% of the company's shares are sold short.
View IRadimed's Short Interest
.

Who are some of IRadimed's key competitors?

What other stocks do shareholders of IRadimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), Crispr Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

Who are IRadimed's key executives?

IRadimed's management team includes the following people:
  • Mr. Roger E. Susi, Founder, Chairman, CEO & Pres (Age 67, Pay $488.45k)
  • Mr. Christopher K. Scott, CFO & Sec. (Age 50, Pay $337.77k)
  • Ms. Mary Beth Smith, VP of Sales

What is IRadimed's stock symbol?

IRadimed trades on the NASDAQ under the ticker symbol "IRMD."

Who are IRadimed's major shareholders?

IRadimed's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Foundry Partners LLC (0.72%), Assenagon Asset Management S.A. (0.51%), Cadence Capital Management LLC (0.13%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own IRadimed stock include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen and Steven M Nardi.
View institutional ownership trends for IRadimed
.

Which major investors are selling IRadimed stock?

IRMD stock was sold by a variety of institutional investors in the last quarter, including Cadence Capital Management LLC. Company insiders that have sold IRadimed company stock in the last year include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen, and Steven M Nardi.
View insider buying and selling activity for IRadimed
.

Which major investors are buying IRadimed stock?

IRMD stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Foundry Partners LLC, and Nisa Investment Advisors LLC.
View insider buying and selling activity for IRadimed
.

How do I buy shares of IRadimed?

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is IRadimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $21.95.

How big of a company is IRadimed?

IRadimed has a market capitalization of $268.82 million and generates $38.52 million in revenue each year. The medical equipment provider earns $9.63 million in net income (profit) each year or $0.78 on an earnings per share basis. IRadimed employs 114 workers across the globe.

What is IRadimed's official website?

The official website for IRadimed is www.iradimed.com.

How can I contact IRadimed?

IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.